Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Davita Inc (DVA) vs Texas Instruments Incorporated (TXN) Price & Performance

Davita IncTrade
Texas Instruments IncorporatedTrade

Price performance (Past 24H)

Key statistics

Davita Inc vs Texas Instruments Incorporated — how do they compare? Davita Inc trades at $232.01 (market cap $15.12B), while Texas Instruments Incorporated trades at $309.4 (market cap $271.73B). The key difference: Texas Instruments Incorporated is far larger — about 18× Davita Inc's market cap, and Texas Instruments Incorporated pays a 1.9% dividend while Davita Inc pays none. Which is the better fit depends on your goals.

DVATXN
Market Cap
$15.12B$271.73B
Sector
HealthTechnology
52-Week High
$235.71$332.35
52-Week Low
$103.87$153.33
Enterprise Value
$27.67B$280.67B
Dividend Yield
1.9%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Davita Inc

No Aura AI signal available yet.

Texas Instruments Incorporated

Texas Instruments (TXN) trades at $305.55, down 1.91% with a bearish technical signal. The company shows improving fundamentals with Q1 2026 earnings beat ($1.68 vs $1.36 expected) and revenue growth to $17.68B in 2025. Recent CFO transition to Julie Knecht and strong AI-related demand from data centers provide positive catalysts. Valuation remains elevated with P/E of 51.04 and P/S of 14.78, while maintaining strong profitability with 29.11% net margin and 32.18% ROE.

TXN presents a mixed outlook with solid fundamentals offset by premium valuation. The stock offers exposure to growing AI infrastructure demand and operational improvements, but faces risks from competitive pressures and debt levels. Analyst consensus leans bullish with $317.20 price target, though technical indicators suggest near-term caution. The current price near pivot point resistance requires monitoring for breakout confirmation.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Davita Inc

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

Read more on DVA

About Texas Instruments Incorporated

Dallas-based Texas Instruments generates over 95% of its revenue from semiconductors and the remainder from its well-known calculators. Texas Instruments is the world's largest maker of analog chips, which are used to process real-world signals such as sound and power. Texas Instruments also has a leading market share position in processors and microcontrollers used in a wide variety of electronics applications.

Read more on TXN